JACKIE HUANG: Open Payments
NPI 1346600681 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,734 in 228 payments from 50 companies in 2025. Trend: 2023 $1,930 · 2024 $2,129 · 2025 $6,734
Food & beverage: $6,519Education: $264
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $855 |
| AstraZeneca Pharmaceuticals LP | 17 | $676 |
| PFIZER INC. | 20 | $634 |
| Astellas Pharma US Inc | 5 | $252 |
| Ipsen Biopharmaceuticals, Inc | 8 | $218 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $216 |
| Merck Sharp & Dohme LLC | 6 | $187 |
| Gilead Sciences, Inc. | 3 | $182 |
| Stemline Therapeutics Inc. | 6 | $181 |
| Daiichi Sankyo Inc. | 16 | $177 |
Products named: RYBREVANT, Xtandi, Enhertu, Nubeqa, Trodelvy, Onivyde, Orserdu, Epkinly.
Industry payments across CA — which companies pay providers there.
